Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K220825
    Date Cleared
    2022-07-08

    (109 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Sapphire Pro Powder-Free Royal Blue Nitrile Exam Gloves

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment for Medical Gloves to Permeation by Chemotherapy Drugs.

    Device Description

    The Sapphire Pro Powder-Free Royal Blue Nitrile Exam Gloves are non-sterile, single use, disposable gloves intended for medical purposes to be worn on the hands of examiners to prevent contamination between a patient and an examiner. The gloves are nitrile, powder-free, ambidextrous, and blue-colored with a beaded cuff. The range of sizes includes small, medium, large, and extra-large.

    AI/ML Overview

    The provided document is a 510(k) summary for the Sapphire Pro Powder-Free Royal Blue Nitrile Exam Gloves, detailing their substantial equivalence to a predicate device. It includes information on acceptance criteria and performance for various tests relevant to examination gloves, particularly concerning permeation by chemotherapy drugs and fentanyl.

    Here's an analysis of the acceptance criteria and the study that proves the device meets them, based solely on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The document provides a "Summary of Nonclinical Testing" table. This section outlines the tests performed, their purpose, acceptance criteria, and the results for the Sapphire Pro Powder-Free Royal Blue Nitrile Exam Gloves.

    Name of Test / StandardPurposeAcceptance CriteriaReported Device Performance (Results)
    ISO 10993-10:2010 (2014)IrritationPass / FailPass – Under the conditions of the study, the subject device is not a primary skin irritant.
    ISO 10993-10:2010 (2014)SensitizationPass / FailPass - Under the conditions of the study, the subject device is not a primary skin sensitizer.
    ISO 10993-5:2009 (2014)CytotoxicityPass / FailFail – Under the conditions of the study, the subject device is cytotoxic.
    ISO 10993-11:2017Acute Systemic ToxicityPass / FailPass - Under the conditions of the study, the subject device is not toxic.
    ASTM D6319-19 ASTM D3767-03 (2020)Physical DimensionsLength: 220 mm min.
    Width: 70 mm min.
    Thickness – Palm and Finger: 0.05 mm min.Pass
    ASTM D6978-05 (2019)Permeation of Fentanyl240 minutes breakthrough time min.Pass (>240 minutes breakthrough time for Fentanyl Citrate 100mcg/2ml)
    ASTM D6978-05 (2019)Permeation of Chemotherapy Drugs240 minutes breakthrough time min.Mixed Results (See breakdown below)
    ASTM D5151-19Detection of HolesLeakage detection, AQL 2.5Pass
    ASTM D6124-06 (2017)Residual PowderMax 2.0 mg / glovePass
    ASTM D6319-19 ASTM D412-16 (2021) ASTM D573-04 (2019)Physical Properties (Tensile Strength & Elongation)Tensile Strength: Before Aging ≥ 14 MPa, min; After Aging ≥ 14 MPa, min
    Elongation: Before Aging 500%, min.; After Aging 400%, min.Pass

    Detailed Chemotherapy Drug Permeation Results (from "Indications for Use" section):

    Chemotherapy Drug and ConcentrationBreakthrough Time (minutes)Acceptance Criteria (from table above)
    Carmustine (BNCU) (3.3 mg/ml)25.5240
    Doxorubicin HCl (2.0 mg/ml)>240Pass
    Etoposide (20.0 mg/ml)>240Pass
    5-Fluorouracil (50.0 mg/ml)>240Pass
    Methotrexate (25.0 mg/ml)>240Pass
    Paclitaxel (6.0 mg/ml)>240Pass
    Thiotepa (10.0 mg/ml)47.7240

    Note on Cytotoxicity: The device failed the cytotoxicity test ("Fail – Under the conditions of the study, the subject device is cytotoxic."). However, the conclusion states that the device is "as safe, as effective, and performs as well as or better than the legally marketed predicate device." The comparative table indicates the predicate device was also "cytotoxic," suggesting this is an anticipated characteristic for this type of nitrile glove and not a disqualifying factor for substantial equivalence in this context.

    2. Sample size used for the test set and the data provenance

    The document specifies the tests conducted according to various ASTM and ISO standards for medical gloves. While the standards imply established testing methodologies and sample sizes (e.g., AQL 2.5 for hole detection typically involves specific sample sizes), the exact numerical sample sizes used for each specific test (e.g., for biocompatibility, physical properties, or permeation tests) are not explicitly stated in this summary.

    Data provenance: The tests were conducted according to internationally recognized standards (ASTM, ISO). The document does not specify the country of origin of the data collectors or if the data was retrospective or prospective. It is implied to be prospective testing carried out for the device's clearance.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    This section is not applicable to this document. The "ground truth" for medical gloves like these is established through standardized laboratory testing procedures (e.g., ASTM D6978-05 for permeation, ASTM D6319-19 for physical dimensions, ISO 10993 series for biocompatibility). There are no human "experts" establishing a "ground truth" for classification or diagnosis in the way one would for an AI CAD system for medical imaging. The performance is measured against objective, measurable criteria defined by the standards.

    4. Adjudication method for the test set

    This concept is not applicable as the "test set" involves objective performance testing against established standards, not subjective expert reviews or diagnostic interpretations.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    This concept is not applicable as the device is a medical glove, not an AI-assisted diagnostic tool requiring human reader studies.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

    This concept is not applicable as the device is a medical glove, not an AI algorithm. Its performance is inherent to its physical and chemical properties.

    7. The type of ground truth used

    The "ground truth" for the performance claims of these gloves is based on standardized laboratory test results defined by the relevant ASTM (American Society for Testing and Materials) and ISO (International Organization for Standardization) standards. These include:

    • Physical measurements (e.g., length, width, thickness).
    • Mechanical properties (e.g., tensile strength, elongation).
    • Barrier integrity (e.g., freedom from holes).
    • Chemical resistance (e.g., breakthrough time for drugs).
    • Biocompatibility (e.g., irritation, sensitization, cytotoxicity, systemic toxicity).

    8. The sample size for the training set

    This concept is not applicable as the device is a medical glove, not a machine learning model that requires a training set.

    9. How the ground truth for the training set was established

    This concept is not applicable as the device is a medical glove, not a machine learning model.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1